Compounds > vidarabine
Page last updated: 2024-08-22

vidarabine and Erythrophagocytic Lymphohistiocytosis, Familial

vidarabine has been researched along with Erythrophagocytic Lymphohistiocytosis, Familial in 21 studies

Research

Studies (21)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (19.05)29.6817
2010's15 (71.43)24.3611
2020's2 (9.52)2.80

Authors

AuthorsStudies
Al-Ahmari, A; Al-Dhekri, H; Al-Jefri, A; Al-Mofareh, M; Al-Mousa, H; Al-Muhsen, S; Al-Saud, B; Al-Seraihy, A; Al-Sweedan, S; Alsaedi, H; Arnaout, R; Ayas, M; El-Solh, H; Ghemlas, I; Mohammed, R; Siddiqui, K1
Aquino, VM; Baker, KS; Chellapandian, D; Dávila Saldaña, B; Duncan, CN; Dvorak, CC; Eapen, M; Eckrich, MJ; Gennery, AR; Georges, GE; Hebert, K; Kim, S; Lugt, MV; Marsh, RA; Olson, TS; Pulsipher, MA; Shenoy, S; Stenger, E; Yu, LC1
Jin, JG1
Algeri, M; Aricò, M; Basso, G; Caniglia, M; Cesaro, S; Di Bartolomeo, P; Fagioli, F; Favre, C; Giardino, S; Locatelli, F; Marzollo, A; Merli, P; Messina, C; Pillon, M; Porta, F; Prete, A; Rabusin, M; Ripaldi, M; Rovelli, A; Saglio, F; Sieni, E; Zecca, M; Ziino, O1
Choo, S; Cole, T; Mechinaud, F; Richards, S1
Bredius, RGM; Bresters, D; Jacobse, J; Kollen, WJW; Mensink, H; van der Stoep-Yap, MYEC1
Allen, CE; Andolina, JR; Baker, KS; Bollard, CM; Bryant, C; Burroughs, L; Connelly, J; Dawson, P; Eapen, M; Hanna, R; Kean, L; Marsh, R; Pai, SY; Pulsipher, MA; Ramirez, A; Roehrs, P; Schultz, KR; Shenoy, S; Stenger, EO; Talano, JA1
Behfar, M; Fazlollahi, MR; Ghavamzadeh, A; Hamidieh, AA; Hashemi, S; Moin, M; Pourpak, Z; Yari, K1
Atsuta, Y; Goto, H; Inagaki, J; Inoue, M; Ishii, E; Kato, K; Kawa, K; Koike, K; Ohga, S; Okada, K; Sawada, A; Suzuki, N; Suzuki, R; Yabe, H; Yasutomo, K1
Behfar, M; Fazlollahi, MR; Ghavamzadeh, A; Hamidieh, AA; Hashemi, S; Moin, M; Movahedi, M; Pourpak, Z; Yari, K1
Imamura, Y1
Carey, P; Hurst, E; Jayakody Arachchillage, D; Keenan, F; Menne, T; Moses, S; O'Brien, SG; Wallis, JP1
Bleesing, JJ; Davies, SM; Filipovich, AH; Haines, HL; Hornung, L; Jordan, MB; Marsh, RA1
Delgado, D; Hege, K; Quigg, T1
Ayala, E; Kharfan-Dabaja, MA; LaFave, D; Nishihori, T1
Chen, X; Tian, LP; Wang, JS; Wang, Z; Wu, L1
Bot, FJ; Chaker, L; Maartense, E; Segeren, CM1
Adachi, S; Fujita, N; Ishii, E; Kanai, R; Nishi, M; Nishimura, R; Ohga, S; Okamura, T; Sato, E; Sawada, A; Suzuki, N; Yano, J; Yasumi, T; Yasutomo, K1
Cantu-Rodríguez, O; Gomez-Almaguer, D; Gonzalez-Llano, O; Gutierrez-Aguirre, H; Herrera-Garza, J; Jaime-Pérez, J; Mancias-Guerra, C1
Attarbaschi, A; Fritsch, G; Gadner, H; Lawitschka, A; Lion, T; Matthes-Martin, S; Minkov, M; Mittheisz, E; Steiner, M; Zoubek, A1
Goto, H; Ito, S; Kajiwara, R; Kuroki, F; Yanagimachi, M; Yokosuka, T; Yokota, S1

Reviews

1 review(s) available for vidarabine and Erythrophagocytic Lymphohistiocytosis, Familial

ArticleYear
[Hemophagocytic lymphohistiocytosis].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2014, Volume: 55, Issue:2

    Topics: Antibodies, Monoclonal, Murine-Derived; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Cyclosporine; Disease Progression; Doxorubicin; Drug Therapy, Combination; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphohistiocytosis, Hemophagocytic; Methotrexate; Multiple Organ Failure; Prednisolone; Prednisone; Rituximab; Severity of Illness Index; Transplantation Conditioning; Vidarabine; Vincristine

2014

Trials

2 trial(s) available for vidarabine and Erythrophagocytic Lymphohistiocytosis, Familial

ArticleYear
Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies.
    Blood, 2018, 09-27, Volume: 132, Issue:13

    Topics: Adolescent; Adult; Alemtuzumab; Antineoplastic Agents; Child; Child, Preschool; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Lymphohistiocytosis, Hemophagocytic; Male; Melphalan; Survival Analysis; Transplantation Conditioning; Treatment Outcome; Vidarabine; Young Adult

2018
Feasibility of reduced-intensity conditioning followed by unrelated cord blood transplantation for primary hemophagocytic lymphohistiocytosis: a nationwide retrospective analysis in Japan.
    International journal of hematology, 2013, Volume: 98, Issue:2

    Topics: Adolescent; Allografts; Antilymphocyte Serum; Child; Child, Preschool; Cord Blood Stem Cell Transplantation; Disease-Free Survival; Female; Humans; Immunosuppressive Agents; Infant; Japan; Lymphohistiocytosis, Hemophagocytic; Male; Melphalan; Myeloablative Agonists; Survival Rate; Transplantation Conditioning; Unrelated Donors; Vidarabine

2013

Other Studies

18 other study(ies) available for vidarabine and Erythrophagocytic Lymphohistiocytosis, Familial

ArticleYear
Hematopoietic stem cell transplantation in children with Griscelli syndrome type 2: a single-center report on 35 patients.
    Bone marrow transplantation, 2020, Volume: 55, Issue:10

    Topics: Busulfan; Child; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Lymphohistiocytosis, Hemophagocytic; Neoplasm Recurrence, Local; Piebaldism; Primary Immunodeficiency Diseases; Retrospective Studies; Transplantation Conditioning; Vidarabine

2020
Comparison of hematopoietic cell transplant conditioning regimens for hemophagocytic lymphohistiocytosis disorders.
    The Journal of allergy and clinical immunology, 2022, Volume: 149, Issue:3

    Topics: Busulfan; Cyclophosphamide; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Lymphohistiocytosis, Hemophagocytic; Melphalan; Thiotepa; Transplantation Conditioning; Vidarabine

2022
Fludarabine is effective in treating refractory hemophagocytic lymphohistiocytosis with brucellosis.
    International journal of rheumatic diseases, 2017, Volume: 20, Issue:12

    Topics: Anti-Bacterial Agents; Brucellosis; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Treatment Outcome; Vidarabine

2017
Outcomes of Children with Hemophagocytic Lymphohistiocytosis Given Allogeneic Hematopoietic Stem Cell Transplantation in Italy.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2018, Volume: 24, Issue:6

    Topics: Adolescent; Busulfan; Child; Child, Preschool; Female; Graft Rejection; Hematopoietic Stem Cell Transplantation; Histocompatibility; Humans; Infant; Italy; Lymphohistiocytosis, Hemophagocytic; Male; Recurrence; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine

2018
Single centre results of targeted busulphan, fludarabine and serotherapy conditioning in haematopoietic stem cell transplantation for haemophagocytic lymphohistiocytosis.
    Bone marrow transplantation, 2018, Volume: 53, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Busulfan; Combined Modality Therapy; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunization, Passive; Lymphohistiocytosis, Hemophagocytic; Male; Transplantation Conditioning; Vidarabine

2018
Long-term aprepitant for nausea and vomiting associated with gastroparesis in hematopoietic stem cell transplantation.
    Bone marrow transplantation, 2018, Volume: 53, Issue:10

    Topics: Alemtuzumab; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Busulfan; Cyclosporine; Gastroparesis; Hematopoietic Stem Cell Transplantation; Humans; Infant; Lymphohistiocytosis, Hemophagocytic; Male; Methotrexate; Nausea; Unrelated Donors; Vidarabine; Vomiting

2018
Hematopoietic stem cell transplantation with a reduced-intensity conditioning regimen in pediatric patients with Griscelli syndrome type 2.
    Pediatric transplantation, 2013, Volume: 17, Issue:5

    Topics: Child, Preschool; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Immune System; Immunologic Deficiency Syndromes; Infant; Lymphohistiocytosis, Hemophagocytic; Male; Myeloablative Agonists; Piebaldism; Primary Immunodeficiency Diseases; Prospective Studies; Tissue Donors; Transplantation Conditioning; Treatment Outcome; Vidarabine

2013
Fludarabine-based reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in primary hemophagocytic lymphohistiocytosis.
    European journal of haematology, 2014, Volume: 92, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Lymphohistiocytosis, Hemophagocytic; Male; Myeloablative Agonists; Prospective Studies; Transplantation Chimera; Transplantation Conditioning; Treatment Outcome; Vidarabine

2014
Haemophagocytic lymphohistiocytosis following fludarabine/cyclophosphamide chemotherapy for chronic lymphocytic leukaemia.
    British journal of haematology, 2014, Volume: 166, Issue:1

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Fatal Outcome; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Vidarabine

2014
Outcomes of donor lymphocyte infusion for treatment of mixed donor chimerism after a reduced-intensity preparative regimen for pediatric patients with nonmalignant diseases.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2015, Volume: 21, Issue:2

    Topics: Adolescent; Alemtuzumab; Antibodies, Monoclonal, Humanized; Child; Child, Preschool; Chimerism; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Lymphocyte Transfusion; Lymphohistiocytosis, Hemophagocytic; Lymphoproliferative Disorders; Male; Melphalan; Mucopolysaccharidoses; Myeloablative Agonists; Retrospective Studies; Severe Combined Immunodeficiency; Siblings; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Unrelated Donors; Vidarabine

2015
Alemtuzumab, Fludarabine, Low-Dose TBI, and Double Umbilical Cord Transplant for Primary Graft Failure in a Patient with Recurrent HLH.
    Pediatric blood & cancer, 2016, Volume: 63, Issue:2

    Topics: Alemtuzumab; Antibodies, Monoclonal, Humanized; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; Graft vs Host Disease; Humans; Infant; Lymphohistiocytosis, Hemophagocytic; Male; Recurrence; Salvage Therapy; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation

2016
Haploidentical transplantation as a promising therapy for relapsed hemophagocytic lymphohistiocytosis in an older adult patient.
    Hematology/oncology and stem cell therapy, 2018, Volume: 11, Issue:2

    Topics: Aged; Allografts; Cyclophosphamide; Hematopoietic Stem Cell Transplantation; Humans; Lymphohistiocytosis, Hemophagocytic; Male; Mycophenolic Acid; Tacrolimus; Transplantation Conditioning; Vidarabine

2018
[Clinical analysis of 14 patients with lymphoma associated hemophagocytic syndrome].
    Zhongguo shi yan xue ye xue za zhi, 2009, Volume: 17, Issue:5

    Topics: Humans; Lymphohistiocytosis, Hemophagocytic; Lymphoma; Prognosis; Retrospective Studies; Treatment Outcome; Vidarabine

2009
Haemophagocytic syndrome and Hodgkin's disease variant of Richter's syndrome after fludarabine for CLL.
    European journal of haematology, 2010, Volume: 85, Issue:1

    Topics: Aged; Antineoplastic Agents; Epstein-Barr Virus Infections; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphohistiocytosis, Hemophagocytic; Male; Vidarabine

2010
Reduced-intensity conditioning in unrelated donor cord blood transplantation for familial hemophagocytic lymphohistiocytosis.
    American journal of hematology, 2012, Volume: 87, Issue:6

    Topics: Blood Component Transfusion; Blood Donors; Child, Preschool; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; Disease-Free Survival; Female; Graft Survival; Graft vs Host Disease; Humans; Infant; Infant, Newborn; Japan; Lymphohistiocytosis, Hemophagocytic; Male; Melphalan; Reoperation; Retrospective Studies; Salvage Therapy; Transplantation Conditioning; Treatment Outcome; Vidarabine; Whole-Body Irradiation

2012
Successful father-to-son stem cell transplantation in a child with hemophagocytic lymphohistiocytosis using a reduced-intensity conditioning regimen.
    European journal of haematology, 2006, Volume: 77, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Etoposide; Family; Graft vs Host Disease; Humans; Infant; Lymphohistiocytosis, Hemophagocytic; Magnetic Resonance Imaging; Male; Melphalan; Methotrexate; Stem Cell Transplantation; Transplantation Conditioning; Vidarabine

2006
Importance of allogeneic T-cells for disease control after stem cell transplantation for high-risk Langerhans cell histiocytosis.
    Haematologica, 2007, Volume: 92, Issue:1

    Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Bone Marrow Transplantation; Combined Modality Therapy; Drug Therapy, Combination; Etoposide; Female; Graft Survival; Histiocytosis, Langerhans-Cell; Humans; Infant; Lymphocyte Transfusion; Lymphohistiocytosis, Hemophagocytic; Melphalan; Prednisone; Remission Induction; T-Lymphocyte Subsets; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Vinblastine

2007
[Reactivation of familial hemophagocytic lymphohistiocytosis after non-myeloablative cord blood stem cell transplantation resulted in the early graft failure].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2007, Volume: 48, Issue:6

    Topics: Antilymphocyte Serum; Child, Preschool; Cord Blood Stem Cell Transplantation; DNA; Female; Graft Rejection; Histocompatibility Testing; Humans; Killer Cells, Natural; Lymphocyte Activation; Lymphohistiocytosis, Hemophagocytic; Recurrence; T-Lymphocytes; Transplantation Conditioning; Vidarabine

2007